{
    "2018-09-11": [
        [
            {
                "time": "2018-09-11",
                "original_text": "社保基金已经赚万亿人民币 青睐医药生物等六行业",
                "features": {
                    "keywords": [
                        "社保基金",
                        "医药生物",
                        "六行业"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-09-11",
                "original_text": "22只股票封板 工艺商品板块涨幅最大",
                "features": {
                    "keywords": [
                        "股票封板",
                        "工艺商品板块",
                        "涨幅最大"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "工艺商品"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-11",
                "original_text": "医药生物2018年中报总结既9月投资策略：价值渐显，适度乐观",
                "features": {
                    "keywords": [
                        "医药生物",
                        "中报总结",
                        "投资策略",
                        "价值渐显",
                        "适度乐观"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-09-10",
                "original_text": "【数据揭秘】融资客最看好的前20只个股",
                "features": {
                    "keywords": [
                        "数据揭秘",
                        "融资客",
                        "前20只个股"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-09-11",
                "original_text": "医疗保健：15药品拟纳入第32批优先审评程序",
                "features": {
                    "keywords": [
                        "医疗保健",
                        "药品",
                        "优先审评程序"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗保健"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-09-11",
                "original_text": "28股获券商买入评级，东诚药业目标涨幅达49.40%",
                "features": {
                    "keywords": [
                        "券商买入评级",
                        "东诚药业",
                        "目标涨幅"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-09-11",
                "original_text": "迈瑞医疗将登陆创业板",
                "features": {
                    "keywords": [
                        "迈瑞医疗",
                        "创业板",
                        "登陆"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗保健"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-09-11",
                "original_text": "社保基金长期重仓股名单曝光，连续五年坚守24只个股",
                "features": {
                    "keywords": [
                        "社保基金",
                        "长期重仓",
                        "24只个股"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-09-11",
                "original_text": "医药生物行业:疫苗企业未发现质量安全问题,进口抗癌药专项采购启动",
                "features": {
                    "keywords": [
                        "医药生物",
                        "疫苗企业",
                        "质量安全",
                        "抗癌药",
                        "专项采购"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-09-11",
                "original_text": "乐普医疗事件点评:肿瘤免疫治疗进入战略部署阶段",
                "features": {
                    "keywords": [
                        "乐普医疗",
                        "肿瘤免疫治疗",
                        "战略部署"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗保健"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}